Skip to Main Content
Back to News

Insider Sale: Chief Medical Officer of $PCRX (PCRX) Sells 879 Shares

Automated

JONATHAN SLONIN, the Chief Medical Officer of $PCRX ($PCRX), sold 879 shares of the company on 01-06-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares. Following this trade, they now own 93,443 shares of $PCRX stock.

$PCRX Insider Trading Activity

$PCRX insiders have traded $PCRX stock on the open market 10 times in the past 6 months. Of those trades, 6 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $PCRX stock by insiders over the last 6 months:

  • JONATHAN SLONIN (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,824 shares.
  • DARYL GAUGLER (Chief Operating Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,000 shares.
  • MARCELO BIGAL has traded it 2 times. They made 2 purchases, buying 4,912 shares and 0 sales.
  • LAURA BREGE purchased 1,000 shares.
  • MICHAEL J. YANG purchased 2,000 shares.
  • MARK FROIMSON purchased 1,400 shares.
  • FRANK D. LEE (Chief Executive Officer) purchased 8,264 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PCRX Hedge Fund Activity

We have seen 131 institutional investors add shares of $PCRX stock to their portfolio, and 154 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles